Tag: Geographic Atrophy (GA)

Stealth BioTherapeutics Announces Data from the Phase 2 ReCLAIM-2 Study of Elamipretide in Geographic Atrophy at the Clinical Trials at the Summit Meeting 2022

Press Release / May 23, 2022August 24, 2026

Stealth Biotherapeutics Announces Data from ReCLAIM-2 Phase 2 Trial of Elamipretide in Geographic Atrophy

Press Release / May 2, 2022August 24, 2026

2026
2025
2024
2023
2022
2019
2018
2016

References
Privacy Policy
Cookie Notice
Terms of Use
123 Highland Ave, Suite 201, Needham, MA 02494
Email Us

You are about to enter a third-party website that is not owned or controlled by Mighty Therapeutics. We are not responsible for the content, security, or privacy practices of any third-party website.